Skip to main content
OpenTrials
Completed

NCT Number: NCT06051526

The African Critical Illness Outcomes Study

In Africa, the prevalence of critical illness is likely to be higher due to a greater burden of disease, and the associated mortality higher due to limited resources. This is a prospective, observational study to rapidly establish the prevalence of critical illness in in-hospital adult patients in Africa, and the resources available to provide essential critical care (care that should be available to every patient in the world) and factors associated with mortality. Rapid dissemination of these findings may help mitigate mortality from critical illness in Africa. These points provide the rationale for the African Critical Illness Outcomes Study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Merowe Daman Hospital

Khartoum, Sudan

About this study

STUDY OBJECTIVES

The objectives of this study are to determine:

  • The proportion of hospital patients who are critically ill,
  • The mortality associated with critical illness,
  • The proportion of critically ill patients who receive essential emergency and critical care,
  • The relationship between essential emergency and critical care provision, and mortality, and
  • The availability of resources necessary to provide essential emergency and critical care.

STUDY DESIGN

An African multi-centre prospective observational cohort study of adult (≥18 years) in-hospital patients. Patient follow up will be for a maximum of 7 days in-hospital.

The primary outcome is in-hospital mortality in adult hospital patients with and without critical illness in Africa.

The intention is to provide a representative sample of the mortality, the risk factors associated with mortality in adult patients with critical illness, and the resources available and interventions provided to treat critical illness in Africa. This study will run between September and November 2023.

PREPARATORY WORK

This study will be run by the African Perioperative Research Group (APORG), with a network of over 600 hospitals in more than 40 African countries which has successfully conducted the African Surgical Outcomes Study (ASOS), the ASOS-2 Trial, the African COVID-19 Critical Care Outcomes Study (ACCCOS) and the African Pediatric Surgical Outcomes Study (ASOS-PEDS).

IMPORTANCE OF THIS STUDY

To decrease the mortality associated with critical illness in Africa, it is important to rapidly establish the potential risk factors for mortality, and resources available to manage these patients. The APORG network has the capacity to provide these data timeously.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All adult patients aged 18 years or over who have been admitted for inpatient care in any department or ward in participating hospitals.

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Presence of critical illness

    Time frame: 7 days

    The number of participants with critical illness.

  2. In-hospital mortality (censored at 7-days)

    Time frame: 7 days

    The number of participants with in-hospital mortality (censored at 7-days)

Secondary outcomes

  1. Provision of essential emergency and critical care

    Time frame: 7 days

    To number of critically ill patients who receive essential emergency and critical care.

  2. Length of hospital stay

    Time frame: 7 days

    The length of hospital stay for critically ill patients

  3. Number of essential emergency and critical care resources available for care

    Time frame: 7 days

    The number of essential emergency and critical care resources available

Sponsors and collaborators

Lead sponsor

University of Cape Town

Other

Collaborators

  • Muhimbili University of Health and Allied Sciences

Registry information

Acronym: ACIOS

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Sep 25, 2023
Registry last updated
Apr 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.